SanBio Future Growth
Future criteria checks 2/6
SanBio is forecast to grow earnings and revenue by 15% and 53.8% per annum respectively. EPS is expected to grow by 15.5% per annum. Return on equity is forecast to be -134.7% in 3 years.
Key information
15.0%
Earnings growth rate
15.5%
EPS growth rate
| Biotechs earnings growth | 10.7% |
| Revenue growth rate | 53.8% |
| Future return on equity | -134.7% |
| Analyst coverage | Low |
| Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 1/31/2027 | 3,286 | -1,302 | -1,362 | 103 | 4 |
| 1/31/2026 | 2,033 | -2,134 | -2,609 | -1,273 | 4 |
| 1/31/2025 | N/A | -3,137 | 1,456 | 1,476 | 2 |
| 7/31/2024 | N/A | -2,166 | -3,880 | -3,831 | N/A |
| 4/30/2024 | N/A | -2,162 | N/A | N/A | N/A |
| 1/31/2024 | N/A | -2,644 | -4,819 | -4,765 | N/A |
| 10/31/2023 | N/A | -5,684 | N/A | N/A | N/A |
| 7/31/2023 | N/A | -5,192 | -6,106 | -6,094 | N/A |
| 4/30/2023 | N/A | -5,870 | N/A | N/A | N/A |
| 1/31/2023 | N/A | -5,559 | -7,441 | -7,434 | N/A |
| 10/31/2022 | N/A | -3,320 | N/A | N/A | N/A |
| 7/31/2022 | N/A | -4,697 | -7,080 | -7,048 | N/A |
| 4/30/2022 | N/A | -4,132 | N/A | N/A | N/A |
| 1/31/2022 | N/A | -4,677 | -6,602 | -6,546 | N/A |
| 10/31/2021 | N/A | -1,659 | N/A | N/A | N/A |
| 7/31/2021 | N/A | -2,312 | -6,267 | -6,189 | N/A |
| 4/30/2021 | N/A | -2,738 | N/A | N/A | N/A |
| 1/31/2021 | N/A | -3,385 | -5,353 | -5,215 | N/A |
| 10/31/2020 | 23 | -6,718 | N/A | N/A | N/A |
| 7/31/2020 | 20 | -6,316 | -5,619 | -5,430 | N/A |
| 4/30/2020 | 258 | -5,928 | N/A | N/A | N/A |
| 1/31/2020 | 447 | -5,157 | -5,823 | -5,717 | N/A |
| 10/31/2019 | 597 | -4,651 | N/A | N/A | N/A |
| 7/31/2019 | 753 | -3,927 | -4,626 | -4,619 | N/A |
| 4/30/2019 | 772 | -2,819 | N/A | N/A | N/A |
| 1/31/2019 | 741 | -2,920 | -3,974 | -3,968 | N/A |
| 10/31/2018 | 687 | -2,331 | N/A | N/A | N/A |
| 7/31/2018 | 656 | -2,705 | -2,111 | -2,107 | N/A |
| 4/30/2018 | 525 | -3,680 | N/A | N/A | N/A |
| 1/31/2018 | 490 | -3,940 | N/A | -1,906 | N/A |
| 10/31/2017 | 562 | -3,302 | N/A | N/A | N/A |
| 7/31/2017 | 514 | -2,966 | N/A | -3,099 | N/A |
| 4/30/2017 | 447 | -2,655 | N/A | N/A | N/A |
| 1/31/2017 | 949 | -1,835 | N/A | -1,796 | N/A |
| 10/31/2016 | 833 | -2,209 | N/A | N/A | N/A |
| 7/31/2016 | 1,447 | -1,693 | N/A | -1,290 | N/A |
| 4/30/2016 | 1,515 | -1,156 | N/A | N/A | N/A |
| 1/31/2016 | 1,174 | -988 | N/A | -1,362 | N/A |
| 10/31/2015 | 1,208 | -647 | N/A | N/A | N/A |
| 1/31/2015 | 3,229 | 1,736 | N/A | -218 | N/A |
| 1/31/2014 | 204 | -589 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4592 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4592 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4592 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4592's revenue (53.8% per year) is forecast to grow faster than the JP market (4.2% per year).
High Growth Revenue: 4592's revenue (53.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4592 is forecast to be unprofitable in 3 years.